Fosaprepitant 150 mg/1 (Fosaprepitant INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 150 mg/1

Fosaprepitant 150 mg/1 is a lyophilized powder for intravenous solution, used primarily for nausea and vomiting prevention. This medication is often used in cancer treatment to manage chemotherapy-induced nausea and vomiting.

Strength

150 mg/1

Pack Size

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0591-4385-79)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fosaprepitant 150 mg/1 is commonly used to prevent nausea and vomiting, particularly in patients undergoing chemotherapy. It is administered intravenously and is designed to provide relief from these symptoms, which can be severe and debilitating. The medication works by blocking certain receptors in the brain that trigger nausea and vomiting, making it a valuable tool in managing these side effects of cancer treatment.

Side Effects

Common effects of Fosaprepitant 150 mg/1 may include fatigue, headache, and constipation. Some patients may also experience dizziness or diarrhea. These effects can vary in intensity and duration, and not everyone will experience them. It is important to discuss any concerns about side effects with a healthcare provider.

Precautions & Warnings

Fosaprepitant 150 mg/1 should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly and to use it only as directed. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant or breastfeeding women should consult their healthcare provider before using this medication.

Avoid Interactions

Fosaprepitant 150 mg/1 may interact with other medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect how this medication works, so it is best to discuss any dietary or lifestyle changes with your healthcare provider.

Frequently Asked Questions

Fosaprepitant 150 mg/1 is used to prevent nausea and vomiting, particularly in patients undergoing chemotherapy.

Fosaprepitant 150 mg/1 is administered intravenously as a lyophilized powder for solution.

Common side effects may include fatigue, headache, constipation, dizziness, and diarrhea.

Pregnant women should consult their healthcare provider before using Fosaprepitant 150 mg/1.

Fosaprepitant 150 mg/1 should be stored according to the instructions provided by the manufacturer and healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.